1-methyl-3-isobutylxanthine has been researched along with Graft-Versus-Host Disease in 1 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
O'Shaughnessy, MJ | 1 |
Chen, ZM | 1 |
Gramaglia, I | 1 |
Taylor, PA | 1 |
Panoskaltsis-Mortari, A | 1 |
Vogtenhuber, C | 1 |
Palmer, E | 1 |
Grader-Beck, T | 1 |
Boussiotis, VA | 1 |
Blazar, BR | 1 |
1 other study available for 1-methyl-3-isobutylxanthine and Graft-Versus-Host Disease
Article | Year |
---|---|
Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo.
Topics: 1-Methyl-3-isobutylxanthine; Animals; CD4-Positive T-Lymphocytes; Cell Transplantation; Cyclic AMP; | 2007 |